valine has been researched along with Fatty Liver in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (33.33) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, E; Goto, R; Igata, M; Kawasaki, S; Kawashima, J; Kitano, S; Kondo, T; Matsumura, T; Matsuyama, R; Miyagawa, K; Motoshima, H; Ono, K | 1 |
| Chen, YH; Chen, YY; Qi, CJ; Yuan, L | 1 |
| Clark, SE; Ferrario, CM; Ibdah, JA; Li, W; Sowers, JR; Thyfault, JP; Uptergrove, GM; Wei, Y; Whaley-Connell, AT | 1 |
| Georgescu, EF; Ionescu, R; Mogoanta, L; Niculescu, M; Vancica, L | 1 |
| Chen, B; Du, G; Guo, J; Li, X; Qiang, G; Shi, L; Xuan, Q; Yang, H; Yang, X; Zhang, H; Zhang, L; Zhou, D; Zu, M | 1 |
| JASIK, AD; WILLIAMS, JN | 1 |
| NOMURA, T | 1 |
| Hurlebaus, AJ; Williams, JN | 1 |
| Kazdová, L; Kurtz, TW; Ogihara, T; Pravenec, M; Qi, NR; Sugimoto, K | 1 |
| Assy, N; Bersudsky, I; Grozovski, M; Hussein, O; Szvalb, S | 1 |
| Akisawa, N; Dong, H; Hirose, A; Iwasaki, S; Li, C; Nozaki, Y; Onishi, S; Ono, M; Saibara, T; Takahashi, M; Wang, J | 1 |
| Fujita, K; Inamori, M; Iwasaki, T; Kirikoshi, H; Maeyama, S; Mawatari, H; Nakajima, A; Nozaki, Y; Saito, S; Takahashi, H; Terauchi, Y; Wada, K; Yoneda, M | 1 |
| Clark, SE; Ferrario, CM; Ibdah, JA; Morris, EM; Sowers, JR; Thyfault, JP; Uptergrove, GM; Wei, Y; Whaley-Connell, AT | 1 |
| Hevia, P; Kari, FW; Ulman, EA; Visek, WJ | 1 |
| Chin, M; Doi, H; Komatsu, H; Mori, S; Nishihira, T; Satomi, S; Shineha, R | 2 |
| Coward, WA; Lunn, PG; Whitehead, RG | 1 |
| Carbonneau, R; Demers, JM | 1 |
1 trial(s) available for valine and Fatty Liver
| Article | Year |
|---|---|
Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis.
Topics: Alanine Transaminase; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Aspartate Aminotransferases; Benzimidazoles; Benzoates; Blood Pressure; Fatty Liver; Female; Humans; Hypertension; Liver Function Tests; Male; Middle Aged; Patient Selection; Telmisartan; Tetrazoles; Valine; Valsartan | 2009 |
17 other study(ies) available for valine and Fatty Liver
| Article | Year |
|---|---|
Effects of combination therapy with vildagliptin and valsartan in a mouse model of type 2 diabetes.
Topics: Adamantane; Adiponectin; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Drug Therapy, Combination; Fatty Liver; Homeodomain Proteins; Inflammation; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Mice; Mice, Inbred C57BL; Nitriles; Phlorhizin; Pyrrolidines; Tetrazoles; Trans-Activators; Valine; Valsartan; Vildagliptin | 2013 |
[The effects of renin-angiotensin system blockade on the liver steatosis in rats on long-term high-fat diet].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Dietary Fats; Fatty Liver; Immunohistochemistry; Insulin Resistance; Ion Channels; Liver; Male; Mitochondrial Proteins; Perindopril; Rats; Rats, Wistar; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Time Factors; Transforming Growth Factor beta1; Uncoupling Protein 2; Valine; Valsartan | 2008 |
Oxidative stress-mediated mitochondrial dysfunction contributes to angiotensin II-induced nonalcoholic fatty liver disease in transgenic Ren2 rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Blotting, Western; Cyclic N-Oxides; DNA, Mitochondrial; Fatty Acids; Fatty Liver; Gene Expression; Immunohistochemistry; Male; Microscopy, Electron, Transmission; Mitochondria; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Reverse Transcriptase Polymerase Chain Reaction; Spin Labels; Tetrazoles; Valine; Valsartan | 2009 |
Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Progression; Fatty Liver; Gene Expression Regulation; Hepatocytes; In Situ Nick-End Labeling; Liver Cirrhosis, Experimental; Mitochondria, Liver; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Tetrazoles; Valine; Valsartan | 2012 |
A MARKEDLY ANTI-LIPOTROPIC ACTION OF METHIONINE.
Topics: Chemical Phenomena; Chemistry; Cholesterol; Cystine; Fatty Liver; Glycerides; Lipid Metabolism; Lipotropic Agents; Liver; Methionine; Phospholipids; Protein Deficiency; Rats; Research; Valine | 1963 |
[HISTOLOGICAL STUDIES OF NUCLEIC ACIDS OF THE LIVER IN DIETARY LIVER DISORDERS. 3. RESULTS WITH A DIET OF BUCKWHEAT FLOUR WITH ADDED AMINO ACIDS].
Topics: Amino Acids; Arginine; Diet; Edible Grain; Fagopyrum; Fatty Liver; Flour; Histidine; Isoleucine; Leucine; Lipotropic Agents; Liver; Lysine; Methionine; Mice; Phenylalanine; Research; RNA; Threonine; Tryptophan; Valine | 1964 |
RESPONSE OF THE LIVER TO PROLONGED PROTEIN DEPLETION. V. NEUTRAL GLYCERIDES AND CHOLESTEROL; PRODUCTION OF FATTY LIVERS BY CERTAIN AMINO ACIDS FED IN A PROTEIN-FREE RATION.
Topics: Amino Acids; Cholesterol; Cystine; Dietary Fats; Dietary Proteins; Fatty Liver; Glycerides; Leucine; Liver; Methionine; Pharmacology; Phenylalanine; Phospholipids; Protein Deficiency; Proteins; Rats; Research; Valine; Zea mays | 1965 |
Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis.
Topics: Adipocytes; Adipose Tissue; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cell Count; Cell Size; Energy Metabolism; Fatty Liver; Gene Expression; Male; Mitochondria; Rats; Rats, Sprague-Dawley; Telmisartan; Tetrazoles; Valine; Valsartan; Weight Gain | 2006 |
Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease.
Topics: Animals; Anticholesteremic Agents; Azetidines; Choline Deficiency; Drug Therapy, Combination; Ezetimibe; Fats; Fatty Liver; Hypoglycemic Agents; Lipid Peroxidation; Liver; Male; Metformin; Oxidative Stress; Rats; Rats, Sprague-Dawley; Rosiglitazone; Tetrazoles; Thiazolidinediones; Tumor Necrosis Factor-alpha; Valine; Valsartan | 2006 |
The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population.
Topics: Adult; Alleles; Asian People; DNA Primers; Fatty Liver; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Japan; Male; Methionine; Middle Aged; Phosphatidylethanolamine N-Methyltransferase; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Valine | 2007 |
Telmisartan, an angiotensin II type 1 receptor blocker, controls progress of nonalcoholic steatohepatitis in rats.
Topics: Actins; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Biomarkers; Blotting, Western; Collagen Type I; Disease Models, Animal; Disease Progression; Fatty Liver; Hypoglycemic Agents; Immunohistochemistry; Male; Pioglitazone; PPAR gamma; Rats; Rats, Inbred F344; Spectrophotometry; Telmisartan; Tetrazoles; Thiazolidinediones; Treatment Outcome; Valine; Valsartan | 2007 |
Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Antihypertensive Agents; Antioxidants; Apoptosis; Blood Pressure; Cyclic N-Oxides; Disease Models, Animal; Fatty Liver; Lipid Peroxidation; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Renin; Renin-Angiotensin System; Spin Labels; Tetrazoles; Valine; Valsartan | 2008 |
Serum lipids of rats fed excess L-lysine and different carbohydrates.
Topics: Amino Acids; Animals; Cholesterol; Dietary Carbohydrates; Dose-Response Relationship, Drug; Fatty Liver; Glutamates; Hyperlipidemias; Lipid Metabolism; Lipids; Liver; Lysine; Male; Phospholipids; Rats; Threonine; Triglycerides; Valine | 1980 |
Effects of caloric intake on anticancer therapy in rats with valine-depleted amino acid imbalance.
Topics: Amino Acids; Animals; Blood Proteins; Body Weight; Energy Intake; Fatty Liver; Lipoproteins, VLDL; Liver; Liver Neoplasms, Experimental; Male; Organ Size; Parenteral Nutrition, Total; Rats; Serum Albumin; Solutions; Triglycerides; Valine | 1997 |
Effect of valine-depleted total parenteral nutrition on fatty liver development in tumor-bearing rats.
Topics: Amino Acids; Animals; Fatty Liver; Kinetics; Lipids; Liver; Liver Neoplasms, Experimental; Male; Neoplasm Transplantation; Parenteral Nutrition, Total; Rats; Vacuoles; Valine | 1998 |
Serum-albumin concentration and the onset of kwashiorkor.
Topics: Alanine; Child; Deficiency Diseases; Fatty Liver; Growth Hormone; Humans; Hydrocortisone; Insulin; Kwashiorkor; Lipoproteins; Prospective Studies; Serum Albumin; Uganda; Valine | 1973 |
[Hepatic steatosis and cholesterolemia in the domestic duckling in the course of protein malnutrition on a rice diet].
Topics: Animals; Arginine; Deficiency Diseases; Fatty Liver; Glutamine; Glycine; Growth; Histidine; Hypercholesterolemia; Isoleucine; Leucine; Lysine; Methionine; Oryza; Phenylalanine; Poultry Diseases; Protein Deficiency; Threonine; Tryptophan; Valine | 1965 |